niacinamide has been researched along with Central Nervous System Disease in 8 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " During pregnancy, some of both groups received zinc or nicotinamide-adenine dinucleotide (NAD) or nicotinamide throughout pregnancy and glucose for gestational day (gd) 15 to 19 with E or W." | 3.66 | Prevention possibility for brain dysfunction in rat with the fetal alcohol syndrome--low-zinc-status and hypoglycemia. ( Arima, M; Nakazawa, K; Suzuki, N; Tanaka, H, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Vandebroek, A | 1 |
| Yasui, M | 1 |
| Baumann, M | 1 |
| Cerny, T | 1 |
| Sommacal, A | 1 |
| Koeberle, D | 1 |
| Tanaka, H | 1 |
| Nakazawa, K | 1 |
| Suzuki, N | 1 |
| Arima, M | 1 |
| Horita, N | 1 |
| Ishii, T | 1 |
| Izumiyama, Y | 1 |
| Halbhübner, K | 1 |
| Herken, H | 2 |
| Loos, D | 1 |
| Sarkander, HI | 1 |
| Knoll-Köhler, E | 1 |
| Cervos-Navarro, J | 1 |
| Wardley-Smith, B | 1 |
| Hudson, S | 1 |
| Doré, CJ | 1 |
| Charlett, A | 1 |
| Fletcher, A | 1 |
| Brammer, NT | 1 |
| Minchin, MC | 1 |
| Wann, KT | 1 |
1 review available for niacinamide and Central Nervous System Disease
| Article | Year |
|---|---|
Regulation of AQP4 in the Central Nervous System.
Topics: Acetazolamide; Animals; Aquaporin 4; Central Nervous System; Central Nervous System Diseases; Homeos | 2020 |
7 other studies available for niacinamide and Central Nervous System Disease
| Article | Year |
|---|---|
Langerhans cell histiocytosis with central nervous system involvement--complete response to 2-chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib.
Topics: Adult; Antineoplastic Agents; Benzamides; Benzenesulfonates; Central Nervous System Diseases; Cladri | 2012 |
Prevention possibility for brain dysfunction in rat with the fetal alcohol syndrome--low-zinc-status and hypoglycemia.
Topics: Animals; Brain; Carbonic Anhydrases; Central Nervous System Diseases; Ethanol; Female; Fetal Alcohol | 1982 |
Ultrastructure of 6-aminonicotinamide (6-AN)-induced lesions in the central nervous system of rats. II. Alterations of the nervous susceptibility with aging.
Topics: 6-Aminonicotinamide; Aging; Animals; Brain Stem; Central Nervous System; Central Nervous System Dise | 1980 |
Experimental neuropathy with Parkinson-like muscular rigidity. A suitable model for testing dopaminergic agonists and neuroleptic drugs.
Topics: 6-Aminonicotinamide; Animals; Antipsychotic Agents; Baclofen; Brain; Brain Chemistry; Bromocriptine; | 1978 |
Repression of glial RNA transcription during the development of 6-aminonic-otinamide (6-AN)-induced acute gliopathy.
Topics: 6-Aminonicotinamide; Animals; Brain; Central Nervous System Diseases; Depression, Chemical; Electrop | 1978 |
Exposure to high pressure may produce the 5-HT behavioral syndrome in rats.
Topics: 5-Hydroxytryptophan; Animals; Atmospheric Pressure; Behavior, Animal; Brain; Carbidopa; Central Nerv | 1990 |
[Pharmacologic studies on the problem of the selective vulnerability of the brain].
Topics: Animals; Antimetabolites; Brain; Central Nervous System Diseases; Electroencephalography; Hippocampu | 1965 |